After-Hours Movers 01/30: (NAVR) (HOLX) (MCK) Higher; (RSH) (REXX) (DRRX) (RCII) Lower
Down)
RadioShack (NYSE: RSH) 19% LOWER; reports preliminary Q4 sales of $1.39 billion and EPS in the range of 11-13 cents. Street currently at $1.35 billion in sales and EPS of 37 cents. Suspending its buyback program. Sees FY12 net income down compared to FY11.
Navarre Corp (NASDAQ: NAVR) 7% HIGHER; reported Q3 GAAP loss of ($0.79), which may not compare with the analyst estimate of ($0.11). Revenue for the quarter came in at $153.5 million versus the consensus estimate of $125.16 million. Sees FY2012 revenue of $460-$480 million, versus the consensus of $442.06 million.
Rex Energy (Nasdaq: REXX) 6.8% LOWER; announces 7 million share common stock offering.
DURECT Corporation (Nasdaq: DRRX) 6.8% LOWER; today reported that Takeda (through Nycomed) has given notice that it is returning its development and commercialization rights to POSIDUR (SABER-Bupivacaine) in Europe and their other licensed territories. Takeda acquired its rights to POSIDUR through its acquisition of Nycomed in September, 2011. POSIDUR is a post-operative pain relief depot that utilizes DURECT's patented SABER technology to deliver bupivacaine and is designed to provide up to three days of pain relief after surgery. Takeda has committed to assist in an orderly and rapid transition of data generated by Nycomed back to DURECT.
Hologic, Inc. (NASDAQ: HOLX) 5.8% HIGHER; reported Q1 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $472.7 million versus the consensus estimate of $466.51 million. Sees Q2 2012 EPS of $0.33, versus the consensus of $0.33. Sees Q2 2012 revenue of $470-$475 million, versus the consensus of $471.01 million. Sees FY2012 EPS of $1.36-$1.38, versus prior guidance of $1.35-$1.37 and the consensus of $1.36.
Rent-A-Center, Inc. (NASDAQ: RCII) 4.9% LOWER; reported Q4 EPS of $0.85, $0.03 better than the analyst estimate of $0.82. Revenue for the quarter came in at $737.5 million versus the consensus estimate of $741.08 million. Same-store sales rose 2.7 percent during the quarter. Sees FY12 sales up 7-10%. Sees GAAP EPS of $3-$3.20, vs. the consensus of $3.22. Sees comps up 2.5-4.5%.
McKesson Corp. (NYSE: MCK) 3.8% HIGHER; reported Q3 EPS of $1.40, $0.03 better than the analyst estimate of $1.37. Revenue for the quarter came in at $30.8 billion versus the consensus estimate of $30.08 billion. Adds $650 million to its buyback program.
Array Biopharma, Inc. (NASDAQ: ARRY) 3.6% HIGHER; reported Q2 EPS of ($0.06), $0.06 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $21.76 million.
Plum Creek Timber Co. (NYSE: PCL) 3.2% LOWER; reported Q4 EPS of $0.37, $0.02 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $356 million versus the consensus estimate of $305.17 million. Sees FY2012 EPS of $1.00-$1.25, versus the consensus of $1.20. Sees Q1 2012 EPS of $0.20-$0.25, versus the consensus of $0.26.
Golub Capital BDC, Inc. (NASDAQ: GBDC) 2% LOWER; announced that it plans to make a public offering of 3,500,000 shares of its common stock. The Company also plans to grant the underwriters an option to purchase up to an additional 525,000 shares of common stock to cover over-allotments, if any.
Coinstar (Nasdaq: CSTR) 1.9% LOWER; announced its President and COO Gregg Kaplan will be taking a leave of absence due to a family illness. The exec expects to return to the company in April of 2012. The company has named Scott Di Valerio, the current CFO, as Interim President of Redbox and Paul Davis, current CEO, as President and COO of Coinstar.
ICU Medical, Inc. (NASDAQ: ICUI) 1.9% LOWER; reported Q4 EPS of $0.70, $0.08 better than the analyst estimate of $0.62. Revenue for the quarter came in at $76.5 million versus the consensus estimate of $78.3 million. Sees FY2012 EPS of $2.45-$2.70, versus the consensus of $2.67. Sees FY2012 revenue of $318-$330 million, versus the consensus of $325.69 million.
Sprint (NYSE: S) 1.4% LOWER; shares falling after hours as RadioShack cited weakness in Sprint's wireless sales.
Advanced Energy Industries, Inc. (NASDAQ: AEIS) 1% LOWER; reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $112.5 million versus the consensus estimate of $113.31 million. Sees Q1 2012 revenue of $95-$105 million, versus the consensus of $100.73 million.
Align Technology, Inc. (NASDAQ: ALGN) INDICATED LOWER; reported Q4 EPS of $0.28, $0.06 better than the analyst estimate of $0.22. Revenue for the quarter came in at $128.9 million versus the consensus estimate of $127.72 million. Sees Q1 2012 EPS of $0.19-$0.21, versus the consensus of $0.22. Sees Q1 2012 revenue of $125.4-$127.9 million, versus the consensus of $129.1 million.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Navarre Corp (NASDAQ: NAVR) 7% HIGHER; reported Q3 GAAP loss of ($0.79), which may not compare with the analyst estimate of ($0.11). Revenue for the quarter came in at $153.5 million versus the consensus estimate of $125.16 million. Sees FY2012 revenue of $460-$480 million, versus the consensus of $442.06 million.
Rex Energy (Nasdaq: REXX) 6.8% LOWER; announces 7 million share common stock offering.
DURECT Corporation (Nasdaq: DRRX) 6.8% LOWER; today reported that Takeda (through Nycomed) has given notice that it is returning its development and commercialization rights to POSIDUR (SABER-Bupivacaine) in Europe and their other licensed territories. Takeda acquired its rights to POSIDUR through its acquisition of Nycomed in September, 2011. POSIDUR is a post-operative pain relief depot that utilizes DURECT's patented SABER technology to deliver bupivacaine and is designed to provide up to three days of pain relief after surgery. Takeda has committed to assist in an orderly and rapid transition of data generated by Nycomed back to DURECT.
Hologic, Inc. (NASDAQ: HOLX) 5.8% HIGHER; reported Q1 EPS of $0.34, $0.02 better than the analyst estimate of $0.32. Revenue for the quarter came in at $472.7 million versus the consensus estimate of $466.51 million. Sees Q2 2012 EPS of $0.33, versus the consensus of $0.33. Sees Q2 2012 revenue of $470-$475 million, versus the consensus of $471.01 million. Sees FY2012 EPS of $1.36-$1.38, versus prior guidance of $1.35-$1.37 and the consensus of $1.36.
Rent-A-Center, Inc. (NASDAQ: RCII) 4.9% LOWER; reported Q4 EPS of $0.85, $0.03 better than the analyst estimate of $0.82. Revenue for the quarter came in at $737.5 million versus the consensus estimate of $741.08 million. Same-store sales rose 2.7 percent during the quarter. Sees FY12 sales up 7-10%. Sees GAAP EPS of $3-$3.20, vs. the consensus of $3.22. Sees comps up 2.5-4.5%.
McKesson Corp. (NYSE: MCK) 3.8% HIGHER; reported Q3 EPS of $1.40, $0.03 better than the analyst estimate of $1.37. Revenue for the quarter came in at $30.8 billion versus the consensus estimate of $30.08 billion. Adds $650 million to its buyback program.
Array Biopharma, Inc. (NASDAQ: ARRY) 3.6% HIGHER; reported Q2 EPS of ($0.06), $0.06 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $21.76 million.
Plum Creek Timber Co. (NYSE: PCL) 3.2% LOWER; reported Q4 EPS of $0.37, $0.02 worse than the analyst estimate of $0.39. Revenue for the quarter came in at $356 million versus the consensus estimate of $305.17 million. Sees FY2012 EPS of $1.00-$1.25, versus the consensus of $1.20. Sees Q1 2012 EPS of $0.20-$0.25, versus the consensus of $0.26.
Golub Capital BDC, Inc. (NASDAQ: GBDC) 2% LOWER; announced that it plans to make a public offering of 3,500,000 shares of its common stock. The Company also plans to grant the underwriters an option to purchase up to an additional 525,000 shares of common stock to cover over-allotments, if any.
Coinstar (Nasdaq: CSTR) 1.9% LOWER; announced its President and COO Gregg Kaplan will be taking a leave of absence due to a family illness. The exec expects to return to the company in April of 2012. The company has named Scott Di Valerio, the current CFO, as Interim President of Redbox and Paul Davis, current CEO, as President and COO of Coinstar.
ICU Medical, Inc. (NASDAQ: ICUI) 1.9% LOWER; reported Q4 EPS of $0.70, $0.08 better than the analyst estimate of $0.62. Revenue for the quarter came in at $76.5 million versus the consensus estimate of $78.3 million. Sees FY2012 EPS of $2.45-$2.70, versus the consensus of $2.67. Sees FY2012 revenue of $318-$330 million, versus the consensus of $325.69 million.
Sprint (NYSE: S) 1.4% LOWER; shares falling after hours as RadioShack cited weakness in Sprint's wireless sales.
Advanced Energy Industries, Inc. (NASDAQ: AEIS) 1% LOWER; reported Q4 EPS of $0.01, in-line with the analyst estimate of $0.01. Revenue for the quarter came in at $112.5 million versus the consensus estimate of $113.31 million. Sees Q1 2012 revenue of $95-$105 million, versus the consensus of $100.73 million.
Align Technology, Inc. (NASDAQ: ALGN) INDICATED LOWER; reported Q4 EPS of $0.28, $0.06 better than the analyst estimate of $0.22. Revenue for the quarter came in at $128.9 million versus the consensus estimate of $127.72 million. Sees Q1 2012 EPS of $0.19-$0.21, versus the consensus of $0.22. Sees Q1 2012 revenue of $125.4-$127.9 million, versus the consensus of $129.1 million.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Unusual 11 Mid-Day Movers 05/25: (GNOM) (UPI) (RPRX) Higher; (TLB) (DCTH) (PAY) Lower
- Morning Movers 05/23: (SCHS) (MELA) (PETM) Higher; (DELL) Lower
- Streetinsider.com's Hot Lunchtime Reads 05/24: (FB) (STP) (TIF) (OVTI) (AAPL)
Create E-mail Alert Related Categories
Special ReportsRelated Entities
After-Hours Movers, Golub CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
